CAH

(redirected from Chronic active hepatitis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to Chronic active hepatitis: hepatitis, Chronic Persistent Hepatitis

CAH

(Critical Access Hospital) See healthcare IT.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
Myasthenia gravis in a patient with chronic active hepatitis C during interferon-a treatment.
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology.
"Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis," Hepatology, 1(1), pp.431-35.
Patients and specimens: A total of 262 patients of different liver diseases [72 acute viral hepatitis (AVH) cases, 49 fulminant hepatic failure (FHF) cases, 93 chronic active hepatitis (CAH) cases and 49 liver cirrhosis (LC) cases] were included in the study.
She had bled so heavily during her teenaged years in the Philippines that she required multiple transfusions and had developed chronic active hepatitis as a result.
A majority of persons who infected with hepatitis C virus will developed chronic active hepatitis and also infected others; about one-fifth of infected respondents will develop cirrhosis or hepatocellular carcinoma if they do not receive intervention (CDC, 1998).
All it took to convince me to switch over was watching one of my residency mentors contract chronic active hepatitis and switch from an active OB practice to pathology.
Into her arm dripped fluid that infected her liver: chronic active hepatitis, non-A, non-B.
Otani S (1995) Randomised trial of effects of interferon-[alpha] on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
The company reported that, while final data has not yet been fully compiled, the Phase I trial for EHC18, its oral immune regulation treatment for hepatitis C-associated chronic active hepatitis, has been completed and preliminary data indicate that the trial endpoints have been met.
Seropositivity to cytomegalovirus, chronic active hepatitis B and C, and herpes zoster were unrelated to new carotid lesion formation.
The first temporal cohort of patients consisted of 35 patients affected by chronic active hepatitis staged according to Desmet et al.

Full browser ?